Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03884582 · ClinicalTrials.gov registry record
Observational Study Using the CoVa Monitoring System 3
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- 14
- Enrollment target
NCT03884582: Completed study, sponsored by Baxter Healthcare Corporation.
NCT03884582 is a clinical trial that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03884582 has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
Asthma is a complex and chronic inflammatory disorder which is associated with reversible airway obstruction and bronchial hyperresponsiveness. It is one of the most prevalent chronic diseases in children and prevalence further increases worldwide. Typical symptoms of asthma are breathlessness, cough, wheezing and chest tightness. These symptoms are particularly prevalent at night-time. Understanding and tracking these symptoms can lead to better management of asthma. Auscultation using a stethoscope is standard clinical practice, however there is currently no available solution to detect respiratory sounds throughout the day and night. The aim of this study is to investigate the feasibility of detecting respiratory sounds in healthy children with the CoVa patch.
Primary Outcome
Subjects will be asked to simulate coughing and wheezing sounds. This data will be analyzed by using a phonocardiogram (microphone) sensor.
Interventions
- DEVICE Cova Monitoring System 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2019-05-01 |
What the finished NCT03884582 record still lists
NCT03884582 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cova Monitoring System 3 is the first listed.
NCT03884582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03884582 about?
NCT03884582 is a clinical study titled "Observational Study Using the CoVa Monitoring System 3". Asthma is a complex and chronic inflammatory disorder which is associated with reversible airway obstruction and bronchial hyperresponsiveness. It is one of the most prevalent chronic diseases in children and prevalence further increases worldwide. Typical symptoms of asthma are breathlessness, coug...
What is the current status of trial NCT03884582?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2019-04-01. Estimated completion is 2019-05-01.
What interventions are being tested in trial NCT03884582?
The interventions under investigation include: Cova Monitoring System 3 (DEVICE).
Who is sponsoring clinical trial NCT03884582?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy